サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1550098

ウェアラブルインジェクター市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年

Wearable Injectors Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 219 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
ウェアラブルインジェクター市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年
出版日: 2024年09月03日
発行: Persistence Market Research
ページ情報: 英文 219 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、ウェアラブルインジェクターの世界市場に関する包括的なレポートを発表しました。当レポートでは、促進要因・動向・機会・課題を含む重要な市場ダイナミクスを徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主要な洞察

  • ウェアラブルインジェクターの市場規模（2024年）：770万米ドル
  • 市場予測金額（2033年）：1,780万米ドル
  • 世界市場成長率（CAGR 2024年～2033年）：9.8%

ウェアラブルインジェクター市場 - レポート範囲：

ウェアラブルインジェクターは、長期間にわたって皮下に薬剤を投与するために設計された高度な医療機器です。これらのデバイスは、糖尿病や関節リウマチなどの慢性疾患管理に対応しており、その利便性と使いやすさから好まれています。ウェアラブルインジェクター市場は、パッチポンプや自動薬剤送達システムなどの技術革新により、患者のコンプライアンスと治療効果を向上させ、病院、クリニック、在宅ケア環境など、さまざまなヘルスケア環境に対応しています。

市場成長の促進要因：

ウェアラブルインジェクターの世界市場は、頻繁な投薬が必要な糖尿病や自己免疫疾患などの慢性疾患の有病率の上昇など、いくつかの重要な要因によって牽引されています。患者に優しく非侵襲的なドラッグデリバリーソリューションに対する需要の高まりとウェアラブル技術の進歩が市場の成長を支えています。センサーや接続機能を統合したスマートなウェアラブルインジェクターなどの技術革新は、薬剤送達の精度と患者モニタリングをさらに強化します。さらに、在宅ヘルスケアソリューションへの動向の高まりと患者中心のケアモデルの採用が市場拡大に寄与しています。

市場抑制要因：

有望な成長見通しにもかかわらず、ウェアラブルインジェクター市場は、高額な機器コスト、規制上のハードル、技術的な複雑さに関連する課題に直面しています。先進的なウェアラブルインジェクターには高額な初期投資が必要であるため、特にヘルスケア予算に制約のある発展途上地域では普及が制限される可能性があります。また、規制当局の承認プロセスや厳しい医療機器規格への準拠も、市場参入や製品開拓の障壁となる可能性があります。さらに、機器の誤作動や定期的なメンテナンスの必要性といった技術的な問題は、ユーザーの満足度や市場浸透に影響を与える可能性があります。

市場機会：

ウェアラブルインジェクター市場は、技術革新、人口動向、ヘルスケア提供モデルの進化によって大きな成長機会がもたらされます。デジタルヘルスプラットフォーム、遠隔モニタリング、人工知能（AI）などの先進技術の統合は、ウェアラブルインジェクターの機能性と魅力を高めます。個別化医療や標的ドラッグデリバリーシステムにおける用途の拡大は、市場成長の新たな道を開きます。戦略的パートナーシップ、研究開発への投資、費用対効果が高く使いやすいウェアラブルインジェクターの開拓は、新たな機会を活用し、市場の主導権を維持するために不可欠です。

本レポートで扱う主要な質問

  • ウェアラブルインジェクター市場の世界的成長を促進する主要な要因は何か？
  • さまざまなヘルスケア環境で最も普及しているウェアラブルインジェクターの種類と用途は？
  • 技術の進歩はウェアラブルインジェクター市場の競合情勢をどのように変えているか？
  • ウェアラブルインジェクター市場に貢献している主要企業はどこで、市場の関連性を維持するためにどのような戦略を採用しているのか？
  • 世界のウェアラブルインジェクター市場の新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲 / 分類
  • 市場の定義 / 範囲 / 制限
  • 包含事項・除外事項

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 市場の革新 / 開発動向

第4章 主要な成功要因

  • 製品採用分析
  • 主要な規制
  • 最近の製品の発売 / 承認
  • PESTEL分析
  • 主要なプロモーション戦略：主要企業別
  • ポーターの分析
  • バリューチェーン分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 製品別
    • エンドユーザー別
    • 国別
  • 2022年の市場シナリオ

第7章 世界のウェアラブルインジェクター市場の需要（金額または規模、百万米ドル）分析

  • 過去の市場金額（百万米ドル）分析、2019年～2023年
  • 現在および将来の市場金額（百万米ドル）予測、2024年～2033年
    • 前年比成長動向分析
    • 絶対額の機会分析

第8章 世界のウェアラブルインジェクター市場分析、製品別

  • イントロダクション/主要な調査結果
  • 過去の市場規模（百万米ドル）の分析、製品別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）分析と予測、製品別、2024年～2033年
    • 身体装着型パッチインジェクター
    • 身体外装着型インジェクター
  • 市場の魅力分析：製品別

第9章 世界のウェアラブルインジェクター市場分析、エンドユーザー別

  • イントロダクション/主要な調査結果
  • 過去の市場規模（百万米ドル）分析、エンドユーザー別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測、エンドユーザー別、2024年～2033年
    • 病院薬局
    • 小売薬局
    • eコマース
  • 市場の魅力分析：エンドユーザー別

第10章 世界のウェアラブルインジェクター市場分析、地域別

  • イントロダクション
  • 過去の市場規模（百万米ドル）の分析、地域別、2019年～2023年
  • 現在および将来の市場金額（百万米ドル）の分析と予測、2024年～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ（MEA）
  • 市場の魅力分析：地域別

第11章 北米のウェアラブルインジェクター市場分析

第12章 ラテンアメリカのウェアラブルインジェクター市場分析

第13章 欧州のウェアラブルインジェクター市場分析

第14章 東アジアのウェアラブルインジェクター市場分析

第15章 南アジアのウェアラブルインジェクター市場分析

第16章 オセアニアのウェアラブルインジェクター市場

第17章 中東・アフリカ（MEA）のウェアラブルインジェクター市場分析

第18章 市場構造分析

  • 市場分析：企業階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第19章 競合分析

  • 競合ダッシュボード
  • 競合の詳細情報
    • Medtronic PLC
    • Enable Injections LLC
    • Becton, Dickinson and Company
    • Insulet Corporation
    • Valeritas,Inc
    • Dexcom, Inc.
    • Ypsomed Group
    • West Pharmaceutical Services, Inc.
    • Bespak
    • Amgen Inc.

第20章 使用される前提条件と頭字語

第21章 調査手法

目次
Product Code: PMRREP21463

Persistence Market Research has recently released a comprehensive report on the worldwide market for wearable injectors. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Wearable Injectors Market Size (2024E): USD 7.7 Million
  • Projected Market Value (2033F): USD 17.8 Million
  • Global Market Growth Rate (CAGR 2024 to 2033): 9.8%

Wearable Injectors Market - Report Scope:

Wearable injectors are advanced medical devices designed to deliver medications subcutaneously over extended periods. These devices cater to chronic disease management, including diabetes and rheumatoid arthritis, and are preferred for their convenience and ease of use. The wearable injectors market serves a range of healthcare settings, including hospitals, clinics, and homecare environments, with innovations such as patch pumps and automated drug delivery systems enhancing patient compliance and treatment efficacy.

Market Growth Drivers:

The global wearable injectors market is driven by several key factors, including the rising prevalence of chronic diseases such as diabetes and autoimmune disorders, which necessitate frequent medication. The increasing demand for patient-friendly and non-invasive drug delivery solutions, coupled with advancements in wearable technology, supports market growth. Innovations such as smart wearable injectors with integrated sensors and connectivity features further enhance drug delivery precision and patient monitoring. Additionally, the growing trend towards home-based healthcare solutions and the adoption of patient-centric care models contribute to the market expansion.

Market Restraints:

Despite promising growth prospects, the wearable injectors market faces challenges related to high device costs, regulatory hurdles, and technical complexities. The high initial investment required for advanced wearable injectors may limit their adoption, particularly in developing regions with constrained healthcare budgets. Regulatory approval processes and compliance with stringent medical device standards can also pose barriers to market entry and product development. Furthermore, technical issues such as device malfunction and the need for regular maintenance can impact user satisfaction and market penetration.

Market Opportunities:

The wearable injectors market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of advanced technologies such as digital health platforms, remote monitoring, and artificial intelligence (AI) enhances the functionality and appeal of wearable injectors. Expanding applications in personalized medicine and targeted drug delivery systems open new avenues for market growth. Strategic partnerships, investment in R&D, and the development of cost-effective and user-friendly wearable injectors are essential to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the wearable injectors market globally?
  • Which wearable injector types and applications are most popular in different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the wearable injectors market?
  • Who are the key players contributing to the wearable injectors market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global wearable injectors market?

Competitive Intelligence and Business Strategy:

Leading players in the global wearable injectors market, including Insulet Corporation, Medtronic PLC, and Tandem Diabetes Care, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced wearable injectors with features such as automated insulin delivery, real-time data monitoring, and connectivity to digital health platforms. Collaborations with healthcare providers, technology firms, and regulatory agencies facilitate market access and promote technology adoption. Emphasis on patient education, clinical trials, and evidence-based practices fosters market growth and enhances patient outcomes in the rapidly evolving wearable injectors landscape.

Key Companies Profiled:

  • Insulet Corporation
  • Medtronic PLC
  • Tandem Diabetes Care
  • Becton, Dickinson and Company
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Roche Holding AG
  • Ypsomed Holding AG
  • Abbott Laboratories
  • Senseonics Holdings, Inc.

Key Segments Covered in Global Wearable Injectors Market Research

Product:

  • Body-worn patch injector
  • Off-body worn injectors

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Key Regulations
  • 4.3. Recent Product launches/ Approvals
  • 4.4. PESTEL Analysis
  • 4.5. Key Promotional Strategies, By Key Players
  • 4.6. Porter's Analysis
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Injectors Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increase in R&D Spending
    • 5.2.2. Growing Lifestyle Disease Prevalence
    • 5.2.3. Cost of Products
    • 5.2.4. Product Features
    • 5.2.5. Advancements in Technology
    • 5.2.6. Changes in Regulatory Policies
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By End User
    • 6.1.3. By Country
  • 6.2. 2022 Market Scenario

7. Global Wearable Injectors Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2033
    • 8.3.1. Body-worn patch injector
    • 8.3.2. Off-body worn injectors
  • 8.4. Market Attractiveness Analysis By Product

9. Global Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. E-commerce
  • 9.4. Market Attractiveness Analysis By End User

10. Global Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 10.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2024-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. East Asia
    • 10.3.5. South Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Product
    • 11.3.3. By End User
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Product
    • 11.4.3. By End User
  • 11.5. Market Trends
  • 11.6. Drivers and Restraints - Impact Analysis
  • 11.7. Key Players - Intensity Mapping
  • 11.8. Country Level Analysis & Forecast
    • 11.8.1. U.S. Wearable Injectors Market Analysis
      • 11.8.1.1. Introduction
      • 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.1.2.1. By Product
        • 11.8.1.2.2. By End User
    • 11.8.2. Canada Wearable Injectors Market Analysis
      • 11.8.2.1. Introduction
      • 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.2.2.1. By Product
        • 11.8.2.2.2. By End User

12. Latin America Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. Mexico
      • 12.3.1.2. Brazil
      • 12.3.1.3. Argentina
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Product
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By End User
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Key Players - Intensity Mapping
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. Mexico Wearable Injectors Market Analysis
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By End User
    • 12.8.2. Brazil Wearable Injectors Market Analysis
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By End User
    • 12.8.3. Argentina Wearable Injectors Market Analysis
      • 12.8.3.1. Introduction
      • 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.3.2.1. By Product
        • 12.8.3.2.2. By End User

13. Europe Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. Italy
      • 13.3.1.3. France
      • 13.3.1.4. U.K.
      • 13.3.1.5. Spain
      • 13.3.1.6. BENELUX
      • 13.3.1.7. Russia
      • 13.3.1.8. Rest of Europe
    • 13.3.2. By Product
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By End User
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Key Players - Intensity Mapping
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Germany Wearable Injectors Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By End User
    • 13.8.2. Italy Wearable Injectors Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By End User
    • 13.8.3. France Wearable Injectors Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By End User
    • 13.8.4. U.K. Wearable Injectors Market Analysis
      • 13.8.4.1. Introduction
      • 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.4.2.1. By Product
        • 13.8.4.2.2. By End User
    • 13.8.5. Spain Wearable Injectors Market Analysis
      • 13.8.5.1. Introduction
      • 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.5.2.1. By Product
        • 13.8.5.2.2. By End User
    • 13.8.6. BENELUX Wearable Injectors Market Analysis
      • 13.8.6.1. Introduction
      • 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.6.2.1. By Product
        • 13.8.6.2.2. By End User
    • 13.8.7. Russia Wearable Injectors Market Analysis
      • 13.8.7.1. Introduction
      • 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.7.2.1. By Product
        • 13.8.7.2.2. By End User

14. East Asia Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
    • 14.3.2. By Product
    • 14.3.3. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. China Wearable Injectors Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By End User
    • 14.8.2. Japan Wearable Injectors Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By End User
    • 14.8.3. South Korea Wearable Injectors Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By End User

15. South Asia Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Indonesia
      • 15.3.1.3. Malaysia
      • 15.3.1.4. Thailand
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Product
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. India Wearable Injectors Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By End User
    • 15.8.2. Indonesia Wearable Injectors Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By End User
    • 15.8.3. Malaysia Wearable Injectors Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By End User
    • 15.8.4. Thailand Wearable Injectors Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By End User

16. Oceania Wearable Injectors Market 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Product
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Australia Wearable Injectors Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By End User
    • 16.8.2. New Zealand Wearable Injectors Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By End User

17. Middle East and Africa (MEA) Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkey
      • 17.3.1.3. North Africa
      • 17.3.1.4. South Africa
      • 17.3.1.5. Rest of Middle East and Africa
    • 17.3.2. By Product
    • 17.3.3. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. GCC Countries Wearable Injectors Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By End User
    • 17.8.2. Turkey Wearable Injectors Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By End User
    • 17.8.3. South Africa Wearable Injectors Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By End User
    • 17.8.4. North Africa Wearable Injectors Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By End User

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Deep Dive
    • 19.2.1. Medtronic PLC
      • 19.2.1.1. Overview
      • 19.2.1.2. Product Portfolio
      • 19.2.1.3. Sales Footprint
      • 19.2.1.4. Key Financials
      • 19.2.1.5. SWOT Analysis
      • 19.2.1.6. Strategy Overview
        • 19.2.1.6.1. Marketing Strategy
        • 19.2.1.6.2. Product Strategy
        • 19.2.1.6.3. Channel Strategy
    • 19.2.2. Enable Injections LLC
      • 19.2.2.1. Overview
      • 19.2.2.2. Product Portfolio
      • 19.2.2.3. Sales Footprint
      • 19.2.2.4. Key Financials
      • 19.2.2.5. SWOT Analysis
      • 19.2.2.6. Strategy Overview
        • 19.2.2.6.1. Marketing Strategy
        • 19.2.2.6.2. Product Strategy
        • 19.2.2.6.3. Channel Strategy
    • 19.2.3. Becton, Dickinson and Company
      • 19.2.3.1. Overview
      • 19.2.3.2. Product Portfolio
      • 19.2.3.3. Sales Footprint
      • 19.2.3.4. Key Financials
      • 19.2.3.5. SWOT Analysis
      • 19.2.3.6. Strategy Overview
        • 19.2.3.6.1. Marketing Strategy
        • 19.2.3.6.2. Product Strategy
        • 19.2.3.6.3. Channel Strategy
    • 19.2.4. Insulet Corporation
      • 19.2.4.1. Overview
      • 19.2.4.2. Product Portfolio
      • 19.2.4.3. Sales Footprint
      • 19.2.4.4. Key Financials
      • 19.2.4.5. SWOT Analysis
      • 19.2.4.6. Strategy Overview
        • 19.2.4.6.1. Marketing Strategy
        • 19.2.4.6.2. Product Strategy
        • 19.2.4.6.3. Channel Strategy
    • 19.2.5. Valeritas,Inc
      • 19.2.5.1. Overview
      • 19.2.5.2. Product Portfolio
      • 19.2.5.3. Sales Footprint
      • 19.2.5.4. Key Financials
      • 19.2.5.5. SWOT Analysis
      • 19.2.5.6. Strategy Overview
        • 19.2.5.6.1. Marketing Strategy
        • 19.2.5.6.2. Product Strategy
        • 19.2.5.6.3. Channel Strategy
    • 19.2.6. Dexcom, Inc.
      • 19.2.6.1. Overview
      • 19.2.6.2. Product Portfolio
      • 19.2.6.3. Sales Footprint
      • 19.2.6.4. Key Financials
      • 19.2.6.5. SWOT Analysis
      • 19.2.6.6. Strategy Overview
        • 19.2.6.6.1. Marketing Strategy
        • 19.2.6.6.2. Product Strategy
        • 19.2.6.6.3. Channel Strategy
    • 19.2.7. Ypsomed Group
      • 19.2.7.1. Overview
      • 19.2.7.2. Product Portfolio
      • 19.2.7.3. Sales Footprint
      • 19.2.7.4. Key Financials
      • 19.2.7.5. SWOT Analysis
      • 19.2.7.6. Strategy Overview
        • 19.2.7.6.1. Marketing Strategy
        • 19.2.7.6.2. Product Strategy
        • 19.2.7.6.3. Channel Strategy
    • 19.2.8. West Pharmaceutical Services, Inc.
      • 19.2.8.1. Overview
      • 19.2.8.2. Product Portfolio
      • 19.2.8.3. Sales Footprint
      • 19.2.8.4. Key Financials
      • 19.2.8.5. SWOT Analysis
      • 19.2.8.6. Strategy Overview
        • 19.2.8.6.1. Marketing Strategy
        • 19.2.8.6.2. Product Strategy
        • 19.2.8.6.3. Channel Strategy
    • 19.2.9. Bespak
      • 19.2.9.1. Overview
      • 19.2.9.2. Product Portfolio
      • 19.2.9.3. Sales Footprint
      • 19.2.9.4. Key Financials
      • 19.2.9.5. SWOT Analysis
      • 19.2.9.6. Strategy Overview
        • 19.2.9.6.1. Marketing Strategy
        • 19.2.9.6.2. Product Strategy
        • 19.2.9.6.3. Channel Strategy
    • 19.2.10. Amgen Inc.
      • 19.2.10.1. Overview
      • 19.2.10.2. Product Portfolio
      • 19.2.10.3. Sales Footprint
      • 19.2.10.4. Key Financials
      • 19.2.10.5. SWOT Analysis
      • 19.2.10.6. Strategy Overview
        • 19.2.10.6.1. Marketing Strategy
        • 19.2.10.6.2. Product Strategy
        • 19.2.10.6.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology